14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Clovis Oncology prices

Date Open High Low Close Volume
Feb 10, 2021 $10.44 $10.61 $9.43 $9.54 8 434 149
Feb 09, 2021 $10.12 $10.74 $9.90 $10.29 7 391 588
Feb 08, 2021 $9.35 $11.10 $8.80 $10.34 19 338 803
Feb 05, 2021 $8.08 $9.52 $7.93 $9.36 16 541 251
Feb 04, 2021 $8.25 $8.29 $7.87 $7.99 6 174 912
Feb 03, 2021 $8.12 $8.48 $7.95 $8.16 5 746 156
Feb 02, 2021 $8.32 $8.34 $7.64 $8.17 8 053 256
Feb 01, 2021 $8.30 $8.57 $7.88 $8.46 8 041 765
Jan 29, 2021 $8.58 $8.67 $7.69 $7.90 8 080 972
Jan 28, 2021 $8.45 $9.48 $7.48 $8.41 22 544 119
Jan 27, 2021 $9.20 $9.55 $7.90 $7.94 22 867 390
Jan 26, 2021 $8.25 $8.57 $7.61 $8.21 14 928 130
Jan 25, 2021 $6.80 $7.96 $6.76 $7.90 17 351 516
Jan 22, 2021 $6.27 $7.10 $6.13 $6.68 8 643 334
Jan 21, 2021 $6.64 $6.70 $6.22 $6.38 4 628 947
Jan 20, 2021 $6.15 $6.74 $6.07 $6.56 9 326 399
Jan 19, 2021 $5.69 $6.37 $5.57 $6.12 8 711 582
Jan 15, 2021 $5.96 $5.98 $5.57 $5.58 5 217 467
Jan 14, 2021 $5.70 $5.96 $5.54 $5.96 4 674 543
Jan 13, 2021 $5.98 $6.14 $5.58 $5.62 6 462 690
Jan 12, 2021 $5.60 $5.97 $5.43 $5.97 7 147 491
Jan 11, 2021 $5.22 $5.74 $5.10 $5.62 9 805 547
Jan 08, 2021 $5.04 $5.19 $4.93 $5.05 4 180 397
Jan 07, 2021 $4.87 $5.04 $4.85 $4.98 4 015 910
Jan 06, 2021 $4.83 $5.01 $4.73 $4.81 3 758 516
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT